A Single Psilocybin Trip Teft Traces in the Brain Weeks Later

A single 25-milligram dose of psilocybin briefly pushed the brains of psychedelic novices into a more chaotic, flexible state—and some traces of the experience were still visible a month later.

A single powerful dose of psilocybin sent the brains of psychedelic novices into a state they had never known before—and left behind measurable traces a month later.

In a new imaging study of 28 healthy adults who had never taken psychedelics, researchers found that a 25-milligram dose of psilocybin, the mind-altering compound in magic mushrooms, briefly made brain activity more varied and unpredictable. That neural “shake-up” may have enabled psychological insights the next day and better self-reported well-being a month later.

The study also found hints of changes in white matter, the brain’s wiring—a result that could help explain why a single psychedelic experience can feel fleeting yet remain psychologically durable.

A Monitored First Trip

The new study followed volunteers through two sessions. In the first, they received 1 milligram of psilocybin, low enough to act like a placebo. A month later, they received 25 milligrams, a dose strong enough to produce a major psychedelic experience.

Researchers monitored the participants with EEG, which records electrical activity through the scalp, during the trip. They also used MRI, including functional MRI and diffusion tensor imaging (DTI), before and after dosing to look for changes in brain activity and white-matter tracts—bundles of nerve fibers that carry signals between brain regions.

“No one has ever properly tested whether and how the brain changes when someone takes psychedelics for the first time,” Robin Carhart-Harris, a neurologist at the University of California, San Francisco, told Scientific American.

The high-dose session was unmistakable. The researchers report that all but one participant rated the 25-milligram experience as the “single most unusual state of consciousness” of their lives. The remaining participant placed it among their top five.

Brain Entropy Spike

During the strongest phase of the trip, EEG recordings showed a rise in brain entropy. In plain terms, the brain’s activity became less repetitive and more varied.

×

Get smarter every day...

Stay ahead with ZME Science and subscribe.

Daily Newsletter
The science you need to know, every weekday.

Weekly Newsletter
A week in science, all in one place. Sends every Sunday.
No spam, ever. Unsubscribe anytime. Review our Privacy Policy.

Thank you! One more thing...

Please check your inbox and confirm your subscription.

RelatedPosts

If Hearing People Chew Makes You Furious, You Might Have a Condition Linked to Anxiety, Depression and PTSD
The Human brain might be organized a whole lot simpler than previously thought. Imaging reveals 3-D grid structure
Older people believe their own lies
Researchers Assessed Antidepressants by Side Effects and Found Some Big Differences

That pattern tracked with what participants later described as psychological insight, including new ways of thinking about themselves, their memories, their problems, or their lives. The stronger the rise in entropy, the more likely a person was to report insight the next day. Those insights, in turn, helped predict improved well-being one month later.

“We know what’s going on in your brain when you’re under the influence—when you’re experiencing the ‘magic’—and we know what it will translate to soon after in terms of psychological insight,” Carhart-Harris added.

The finding gives weight to a central debate in psychedelic science: whether the trip itself matters. The new results suggest the subjective experience may indeed play a role in the later benefits, rather than acting as a colorful side effect.

“Our data shows that such experiences of psychological insight relate to an entropic quality of brain activity and how both are involved in causing subsequent improvements in mental health,” Carhart-Harris explained.

A Potential Rewiring

A month later, the DTI scans offered the study’s most provocative clue. They suggested changes in tracts running from the prefrontal cortex—the decision-making and self-reflection center—toward deeper brain structures, including the striatum and thalamus.

The researchers found decreased axial diffusivity, a measure of how water moves along nerve fibers. That could mean the fibers became more compact, thinner, newly grown, pruned, or otherwise reorganized. The scan cannot reveal the exact biological cause.

“It’s remarkable to see potential anatomical brain changes one month after a single dose of any drug,” Carhart-Harris told The Guardian. “We don’t yet know what these changes mean, but we do note that overall, people showed positive psychological changes in this study, including improved wellbeing and mental flexibility.”

The authors cautiously call their work exploratory and hypothesis-generating. The study was small, used a fixed order rather than a fully randomized design, and followed participants for only one month. DTI offers an indirect view of tissue structure, so the apparent changes need confirmation with more advanced imaging.

The Promise and the Puzzle

The volunteers were healthy, not patients seeking treatment for depression, addiction, or anxiety. Still, the findings may help explain why psilocybin-assisted therapy has attracted so much attention. The drug may temporarily loosen rigid patterns of brain activity, creating a window in which people can think differently.

“Psilocybin seems to loosen up stereotyped patterns of brain activity and give people the ability to revise entrenched patterns of thought,” said Taylor Lyons of Imperial College London, in a statement.

Outside experts welcomed the study while stressing its limits. “Importantly, it demonstrates the importance of acute and enduring psychological insights or realizations in predicting outcomes of psilocybin experiences,” Alan Davis of Ohio State University told Scientific American.

For now, the study does not show that psilocybin is safe or beneficial for everyone. It does not prove that the brain changes are helpful. And it cannot say how long they last.

“The honest answer is: we don’t know [how psilocybin changes the brain],” Carhart-Harris concluded. “We don’t have enough information.”

The mushroom trip ended after a few hours. The scientific trip has only begun.

The study was published in the journal Nature Communications.